Batchelor-Regan H et al. From Disease Description and Gene Discovery to Functional Cell Pathway: A Decade-Long Journey for TMCO1. Front Genet. 2021:12:652400. https://doi.org/10.3389/fgene.2021.652400. PMID: 34093650.
Caglayan AO et al. Whole-Exome Sequencing Identified a Patient with TMCO1 Defect Syndrome and Expands the Phenotic Spectrum. Clin Genet. 2013;84(4):394–395, https://doi.org/10.1111/cge.12088. PMID: 23320496.
Pehlivan D et al. “Whole-Exome Sequencing Links TMCO1 Defect Syndrome with Cerebro-Facio-Thoracic Dysplasia.” Eur J Hum Genet. 2014;22(9):1145-1148. https://doi.org/10.1038/ejhg.2013.291. PMID: 24424126.
Ratnayake C et al. Brain and spine MRI findings in children presenting with TMCO1 mutation, BJR Case Rep. 2022;8(4)20210253 10.1259/bjrcr20210253. PMID: 36451910.
Sharkia R et al. A Novel Biallelic Loss‐of‐function Mutation inTmco1Gene Confirming and Expanding the Phenotype Spectrum of Cerebro‐facio‐thoracic Dysplasia. Am J Med Genet A. 2019;179(7):1338-1345 https://doi.org/10.1002/ajmg.a.61168. PMID: 31102500.
Wang Q et al. TMCO1 Is an ER ca 2+ Load-Activated ca 2+ Channel. Cell. 2016;165(6):1454–1466, https://doi.org/10.1016/j.cell.2016.04.051. PMID: 27212239.
Xin B et al. Homozygous Frameshift Mutation in Tmco1 Causes a Syndrome with Craniofacial Dysmorphism, Skeletal Anomalies, and Mental Retardation. Proc Natl Acad Sci U S A. 2010;107(1):258–263, https://doi.org/10.1073/pnas.0908457107. PMID: 20018682.